UCB Pharma (United Kingdom)

1.1k papers and 44.0k indexed citations i.

About

In recent decades, authors affiliated with UCB Pharma (United Kingdom) have published 1.1k papers, which have received a total of 44.0k indexed citations. Scholars at this organization have produced 430 papers in Molecular Biology, 308 papers in Immunology and 191 papers in Radiology, Nuclear Medicine and Imaging on the topics of Monoclonal and Polyclonal Antibodies Research (186 papers), Psoriasis: Treatment and Pathogenesis (95 papers) and Spondyloarthritis Studies and Treatments (78 papers). Their work is cited by papers focused on Molecular Biology (19.5k citations), Immunology (8.8k citations) and Oncology (6.4k citations). Authors at UCB Pharma (United Kingdom) collaborate with scholars in United Kingdom, United States and Belgium and have published in prestigious journals including Nature, Science and Cell. Some of UCB Pharma (United Kingdom)'s most productive authors include Jiye Shi, Chunhai Fan, Charlotte M. Deane, Jiang Li and Andrew Docherty.

In The Last Decade

Fields of papers published by authors at UCB Pharma (United Kingdom)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with UCB Pharma (United Kingdom) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at UCB Pharma (United Kingdom)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at UCB Pharma (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at UCB Pharma (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites UCB Pharma (United Kingdom) more than expected).

Rankless by CCL
2025